Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers

Hanon, Olivier; Vidal, Jean‐Sébastien; Lehmann, Sylvain; Bombois, Stéphanie; Allinquant, Bernadette; Tréluyer, Jean‐Marc; Gelé, Patrick; Delmaire, Christine; Blanc, Frédéric; Mangin, Jean‐François; Buée, Luc; Touchon, Jacques; Hugon, Jacques; Vellas, Bruno; Galbrun, Evelyne; Bénétos, Athanase; Berrut, Gilles; Paillaud, Éléna; Wallon, David; Castelnovo, Giovanni; Volpe‐Gillot, Lisette; Paccalin, Marc; Robert, P.H.; Godefroy, Olivier; Dantoine, Thierry; Camus, Vincent; Belmin, Joël; Vandel, Pierre; Novella, Jean‐Luc; Duron, Emmanuelle; Rigaud, Anne‐Sophie; Schraen‐Maschke, Susanna; Gabelle, Audrey; behalf of the BALTAZAR study group, on

doi:10.1016/j.jalz.2018.01.004

Public

Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers

Published in Alzheimer s & Dementia • Feb 16, 2018

Authors:

Olivier Hanon

Jean‐Sébastien Vidal

Sylvain Lehmann

Abstract

Abstract Introduction Diagnostic relevance of plasma amyloid β (Aβ) for Alzheimer's disease (AD) process yields conflicting results. The objective of the study was to assess plasma levels of Aβ 42 and Aβ 40 in amnestic mild cognitive impairment (MCI), nonamnestic MCI, and AD patients and to investig...

Subject

Biomarker

Apolipoprotein E

Cerebrospinal fluid

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!